Zaire Ebola vaccine candidates

Automobiles Hyundai Motor launches global talent recruitment program

South Korea’s top automaker Hyundai Motor Co. has launched a global talent recruitment program, beginning April 1 via its official hiring webs...

IPOs Celltrion seeks large-scale M&A in Q4, eyes 2027 Nasdaq debut

SAN FRANCISCO – South Korea’s leading biosimilar drug developer Celltrion Inc. seeks to acquire a domestic health food maker as early as...

Mergers & Acquisitions Macquarie kicks off sale of DIG Airgas estimated at over $3.4 billion

Macquarie Asset Management has embarked on a process to sell off its 100% stake in South Korea’s third-largest industrial gas producer DIG Air...

Bio & Pharma SK Bioscience, Sanofi to develop next-gen pneumococcal vaccines

South Korea's SK Bioscience Co. said on Friday it signed an expanded agreement with Sanofi to co-develop next-generation pneumococcal conjugate vacc...

Mergers & Acquisitions MBK kicks off Lotte Card sale for about $1.4 bn in 2nd bid

Lotte Card Co. is expected to be up for grabs in the first half of next year amid a second sale attempt by its largest shareholder MBK Partners, a N...

Bio & Pharma Hanmi Pharma to move up launch of anti-obesity drug

South Korea’s Hanmi Pharmaceutical Co. announced on Thursday the launch of its anti-obesity drug candidate efpeglenatide has been rescheduled ...

Energy KEPCO shortlisted for Saudi Arabia's solar energy projects

Korea Electric Power Corp. (KEPCO), the South Korean state-run utility company, was shortlisted as a final candidate for renewable energy projects i...

Bio & Pharma SK Bioscience's SKYCellflu approved in Indonesia

SK Bioscience Co., a bio and pharmaceutical affiliate of South Korea's SK Group, said on Wednesday that The Indonesian Food and Drug Authority BPOM ...

Korean startups Enormous market ahead for Hopae, S.Korean DID pioneer

To Hopae Inc., a digital identity solution-developing startup native to South Korea, its home market is small. After successfully accommodating more...

Bio & Pharma SK Bioscience sells stake in US vaccine developer Novavax

SK Bioscience Co., a drug-making arm of South Korea's No. 2 conglomerate SK Group, has sold a stake in Nasdaq-listed vaccine developer Novavax Inc. ...

Sovereign wealth funds Sovereign wealth fund KIC shortlists three CEO candidates

South Korean sovereign wealth fund Korea Investment Corporation (KIC) has shortlisted three candidates as the next chief executive officer, who will...

Mergers & Acquisitions SK Bioscience to buy German vaccine maker IDT Biologika for $244 mn

South Korea’s vaccine developer SK Bioscience Co. will acquire a controlling stake in the world’s top 10 vaccine firm IDT Biologika GmbH...

Bio & Pharma EuBiologics gets WHO certification for cholera vaccine facility

South Korea's EuBiologics Co. announced on Friday that the vaccine bulk production facility at its Chuncheon Plant No. 2 for the oral cholera vacc...

Tech, Media & Telecom KT, Nokia to collaborate on global 6G research

South Korea's KT Corp. announced on Wednesday that it signed a business agreement with global mobile communications equipment manufacturer Nokia Cor...

Airlines MBK, Air Premia team up for Asiana’s cargo unit; Jeju Air exits

South Korea's low-cost carrier Air Premia Inc. has teamed up with North Asia-focused private equity firm MBK Partners to win Asiana Airlines Inc.'s ...

Corporate governance NPS to vote in favor of KT&G CEO candidate Bang

South Korea’s National Pension Service (NPS), the world’s third-largest pension fund, is slated to vote in favor of the KT&G Corp. b...

Bio & Pharma SK Bioscience exports Sky Cellflu to Thailand

South Korea's SK Bioscience Co. announced on Thursday that it has shipped about 440,000 doses (for single-dose administration) of its cell-cultured ...

Corporate governance ISS urges KT&G shareholders to vote against CEO candidate Bang

Global leading proxy advisor Institutional Shareholder Services Inc. (ISS) has recommended that stakeholders of South Korean tobacco maker KT&G ...

Investment banking Korea's NH Investment shortlists 3 CEO candidates

South Korean brokerage house NH Investment & Securities Co. has shortlisted three candidates for its next chief executive as the current CEO Jeo...

Leadership & Management Tobacco maker KT&G names its COO as final CEO candidate

South Korea’s KT&G Corp., the world’s leading tobacco maker, appointed its Chief Operating Officer Bang Kyung-man as the final candi...

Bio & Pharma Samsung Biologics signs ADC CDO deal with LegoChem Bio

Samsung Biologics Co. has agreed with South Korean biotech company LegoChem Biosciences Inc. to provide contract development organization (CDO) serv...

Bio & Pharma LG Chem to start phase 3 for head, neck cancer drug in US

South Korea’s LG Chem Ltd. announced on Wednesday that its US-based subsidiary Aveo Pharmaceuticals will start Phase 3 clinical trials for its...

Bio & Pharma Kobiolabs gets US patent for oral obesity drug candidate

Kobiolabs Co., a South Korean microbiome-based new drug development company, announced on Wednesday that it has a patent for Roseburia intestinalis ...

Bio & Pharma LG Chem out-licenses obesity drug candidate to US firm

LG Chem Ltd. has agreed to license out a rare genetic obesity drug candidate in phase 2 clinical trials to Rhythm Pharmaceuticals Inc., a US biotech...

Leadership & Management POSCO Holdings’ Chairman Choi to hand over baton

POSCO Holdings Inc.'s Chairman Choi Jeong-woo is not among the company’s next CEO candidates, suggesting Choi will leave the company after ser...

Tech, Media & Telecom Korea’s 6G frequency bands picked as standard candidates

Sixth-generation (6G) communication frequency bands proposed by South Korea have been adopted as global standard candidates by the industry's freq...

Bio & Pharma SK Bioscience start to deliver Novavax COVID-19 vaccine

South Korea's SK Bioscience Co. announced on Tuesday that it started to deliver the Novavax COVID-19 vaccine against XBB.1.5 variant.According to No...

Bio & Pharma SK Bioscience applies Phase 3 trials in US for pneumococcal vaccine

South Korea's SK Bioscience Co. announced on Monday that it submitted the Investigational New Drug (IND) application for the Phase 3 clinical trial ...

Bio & Pharma ISU Abxis gets patent for Alzheimer drug candidate in Taiwan

South Korea's ISU Abxis Co. announced on Friday that its Alzheimer's treatment candidate ISU203 has received a substance patent registration decisio...

Bio & Pharma Korea to invest $200 mn in new drugs, vaccines by 2028

South Korea’s health ministry will allocate 261.6 billion won ($200.2 million) for two funds over the next four years to boost private sector ...